Synthesis and biological evaluation of tyrosine derivatives as peripheral 5HT2A receptor antagonists for nonalcoholic fatty liver disease

This publication has 20 references indexed in Scilit:

• Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
  Gastroenterology, 2015
• Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis
  Nature Medicine, 2014
• Metabolomic Analysis of Livers and Serum from High-Fat Diet Induced Obese Mice
  Journal of Proteome Research, 2010
• The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
  Diabetes, Obesity and Metabolism, 2010
• The Expanded Biology of Serotonin
  Annual Review of Medicine, 2009
• Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
  Progress in Lipid Research, 2009
• Targeting the murine serotonin transporter: insights into human neurobiology
  Nature Reviews Neuroscience, 2008
• Histological assessment of non‐alcoholic fatty liver disease
  Histopathology, 2006
• Treatment of non-alcoholic fatty liver disease
  Postgraduate Medical Journal, 2006
• Nonalcoholic Fatty Liver Disease
  New England Journal of Medicine, 2002